All exams GARBI ESI
In one line
The Government of India approved the Biovigilance Programme of India, to strengthen safety monitoring of medicines and biological products used in organ and tissue transplantation.
Context
What It Is
Free live session
NABARD Grade A 2026: what the 2025 cut-offs changed, and the 90-day plan
In 5 days · Sun, 4 Oct at 7:30 PM IST
- A national patient-safety surveillance programme
- For the systematic reporting, assessment, monitoring and prevention of adverse events associated with medicines and biological products used in transplantation
- Coordinated by the Indian Pharmacopoeia Commission (IPC)
